Two Indians Charged in US for Smuggling and Selling Counterfeit Ozempic from China

Two Indian nationals have been charged in the United States for allegedly selling counterfeit versions of the popular diabetes and weight-loss drug Ozempic. The fake medication was reportedly smuggled into the US from China as part of an organized scheme. The US Food and Drug Administration had seized some of the counterfeit Ozempic in December 2023 and issued a public warning about the products. However, the illegal operation continued even after the FDA's intervention and warning. Authorities have now moved to formally charge the individuals involved in distributing the fraudulent medication.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in